Overview of HBV associated Liver Cirrhosis (Mutation)

ID Literature Title Group
1 30505167 Hepatitis B virus precore G1896A mutation in chronic liver disease patients with HBeAg negative serology from North India
Mutation
2 12436473 Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies
Mutation
3 17030194 Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient
Mutation
4 22342116 Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy
Mutation
5 22882650 Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients
Mutation
6 26577140 Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection
Mutation
7 34920100 Novel X gene point mutations in chronic hepatitis B and HBV related cirrhotic patients
Mutation
8 16618410 High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases
Mutation
9 17203204 Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam
Mutation
10 18551606 Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection
Mutation
11 29285238 Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients
Mutation
12 31565220 Association between host TNF-alpha, TGF-beta1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients
Mutation
13 35415256 Precore/core mutations of hepatitis B virus genotype D arising in different states of infection
Mutation
14 18844615 HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study
Mutation
15 20959817 Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma
Mutation
16 22919746 [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum]
Mutation
17 23272650 Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
Mutation
18 24637457 Mutation profiling of the hepatitis B virus strains circulating in North Indian population
Mutation
19 30043328 Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant
Mutation
20 31341154 Association Between HBx Variations and Development of Severe Liver Disease Among Indonesian Patients
Mutation
21 32523313 Conservation and variability of hepatitis B core at different chronic hepatitis stages
Mutation
22 33296295 Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
Mutation
23 34029727 Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression
Mutation
24 35880842 The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma
Mutation
25 38037048 HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population
Mutation
26 15048802 Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin
Mutation
27 19008175 Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient
Mutation
28 20550526 Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients
Mutation
29 20559531 A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant
Mutation
30 21159112 Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only
Mutation
31 21863638 [One-year combination therapy de novo of adefovir dipivoxil and lamivudine for decompensated cirrhosis related to HBV]
Mutation
32 29739114 Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B
Mutation
33 32860707 Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion
Mutation
34 18508941 Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus
Mutation
35 20419326 Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma
Mutation
36 21323729 Natural history of chronic hepatitis B REVEALed
Mutation
37 21941645 Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
Mutation
38 22720023 Hepatitis B virus gene mutations in liver diseases: a report from New Delhi
Mutation
39 23304671 HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China
Mutation
40 23903686 Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively
Mutation
41 25281206 Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma
Mutation
42 26290395 Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study
Mutation
43 26899956 Molecular characterization of hepatitis B virus from chronically-infected patients in Niamey, Niger
Mutation
44 28373061 Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer
Mutation
45 28654219 A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma
Mutation
46 28902288 Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases
Mutation
47 31105017 Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients
Mutation
48 32155009 [The prevalence clinically significant virus mutations among patients with chronic viral hepatitis B.]
Mutation
49 33947693 The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Mutation
50 24715933 Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran
Mutation
51 9425945 Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
Mutation
52 35809696 Identification of a novel variant of hepatitis B virus isolated from patient co-infected with hepatitis C virus
Mutation
53 30406036 The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease
Mutation
54 31501793 Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.